Intrasense
Intrasense is a French medical imaging software company that develops the Myrian multi-modality visualization platform and proprietary AI lesion detection modules (DUOnco, Liflow) for hospital radiology and oncology departments worldwide. It operates as a subsidiary of Guerbet.
- Company typePublic
- Founded2004
- HeadquartersMontpellier, France
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What Intrasense does
Intrasense is a French medical imaging software company founded in 2004 and headquartered in Montpellier, France, listed on Euronext Growth Paris (ticker ALINS) and operating as a subsidiary of Guerbet, the global medical imaging leader. The company designs, develops, and commercializes the Myrian platform, a multi-modality visualization and analysis environment supporting MRI, CT, mammography, tomosynthesis, and ultrasound imaging, along with a portfolio of specialized clinical applications organized by anatomy and pathology (e.g., Myrian XP-Prostate, XP-Lung, XP-Liver, XP-Breast, XP-Female Pelvis, XP-Cardio, XP-Colon, XP-AbdoFat, XP-Oncology).
The company's AI capability is anchored in proprietary lesion detection algorithms deployed as DUOnco Liver, DUOnco Bone, and DUOnco Pancreas modules and as add-on AI options for Myrian XP-Prostate (PI-CAI Challenge-winning algorithm) and Myrian XP-LungNodule (92.4% sensitivity). Liflow provides automated oncology follow-up with lesion tracking and therapeutic response assessment. All Class II products hold CE marking under MDR 745/2017, and DUOnco Pancreas additionally holds FDA Breakthrough Device designation and PMDA certification in Japan.
Intrasense commercializes primarily through a direct enterprise sales motion targeting hospital radiology departments, oncology centers, and imaging centers on a quote-based subscription/one-time-license model, supplemented by Guerbet's global distribution channel, an AI Hub that integrates third-party imaging AI (Nurea, Milvue, Icometrix ico*brain), and participation in major radiology congresses (JFR, RSNA, ECR, SIRM, SERAM, RöKö, AFIB). Reported FY2025 revenue is €3.2 million (+43% YoY) across 1,200+ clients worldwide, with ~70 employees based in Montpellier.
Intrasense firmographics
Firmographics- Name
- Intrasense
- Legal name
- INTRASENSE
- Website
- https://intrasense.fr
- Company type
- Public
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Intrasense is a French medical imaging software company that develops the Myrian multi-modality visualization platform and proprietary AI lesion detection modules (DUOnco, Liflow) for hospital radiology and oncology departments worldwide. It operates as a subsidiary of Guerbet.
- Ownership category
- akta.pro rank
Intrasense industry classification
Industry- Product category
- Medical Imaging Software
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ)
- akta.pro secondary industry
- Medical Imaging AI (HDAAAEAH)
Keywords
Where Intrasense is headquartered
LocationHeadquarters
- HQ city
- Montpellier
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
Intrasense business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Medical Imaging Software Licensing: Sale of medical device software including Myrian platform, DUOnco suite, and Liflow application. Products are Class II medical devices with CE marking under MDR 745/2017, sold to healthcare professionals and institutions.
- Software Licenses and Updates: Revenue generated from software licenses, version updates (Myrian 2.14), and ongoing product support for the Myrian visualization platform and specialized clinical applications.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise licensing for healthcare institutions |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels5 records
Intrasense product offering
Product offeringCore offering
Intrasense designs and develops Class II medical device software for AI-enhanced medical imaging, centered on the Myrian® multi-modality visualization platform supporting MRI, CT, mammography, tomosynthesis, and ultrasound. The portfolio includes the DUOnco™ family of AI lesion detection modules (Liver, Bone, Pancreas) and the Liflow® automated oncology follow-up application, all sold to radiology departments, oncology centers, and hospitals worldwide.
Product overview
Intrasense offers a unified medical imaging software ecosystem centered on the Myrian® platform, a multi-modality visualization and analysis platform supporting MRI, CT, mammography, tomosynthesis, and ultrasound imaging. The portfolio includes specialized clinical applications organized by anatomy and pathology: Myrian XP-Prostate with optional AI, Myrian XP-Lung/LungNodule with optional AI, Myrian XP-Oncology/Liver/Colon/AbdoFat for abdominal imaging, Myrian XP-Breast/XM-MG/XP-Female Pelvis for women's health, and Myrian XP-Cardio for cardiovascular imaging. AI-enhanced offerings include the DUOnco™ family (Liver, Bone, Pancreas) for automated lesion detection, and Liflow® for automated oncology follow-up. The company also distributes Icometrix's ico**brain** brain imaging solutions and integrates third-party AI through its AI Hub (Nurea, Milvue).
Differentiator
Problem solved
Functional benefit
Brands
- Myrian: Advanced multi-modality visualization platform for medical imaging analysis, processing, and management.
- DUOnco
- Liflow
Products and services
- Myrian® Platform Multi-modality medical imaging platform providing advanced visualization, processing, and analysis of MRI, CT, mammography, tomosynthesis, and ultrasound images. It is the core platform hosting clinical applications and AI solutions for radiology workflows, sold to hospitals and radiology departments.
- DUOnco™ Pancreas Software for automatic detection and measurement of pancreatic focal lesions and main pancreatic duct in contrast CT images. Class II medical device with CE marking, FDA Breakthrough Device designation, and PMDA certification in Japan, intended for oncology and radiology specialists.
- DUOnco™ Liver Software for automatic detection and measurement of hepatic lesions in contrast-enhanced CT images (portal phase). Class II medical device with CE marking, used by radiologists and oncologists.
- DUOnco™ Bone Software for automatic detection of bone lesions in CT images. Class II medical device with CE marking under MDR 745/2017, for radiology and oncology use.
- Liflow® AI-enhanced application dedicated to automated oncology follow-up and interpretation of oncology examinations. Automates lesion tracking, therapeutic response assessment, and structured reporting for cancer patient monitoring, used by oncology specialists and radiologists.
- ico*brain (Icometrix) Brain imaging analysis solutions including ico*brain mr (MR brain structure labeling and volumetric quantification), ico*brain ct (CT brain structure analysis), and ico*brain ctp (CT perfusion analysis for cerebral blood flow and volume). Class IIa medical devices distributed by Intrasense through partnership with Icometrix.
- Myrian XP-Prostate Option AI AI option for Myrian XP-Prostate that analyzes multiparametric prostate MRI scans, automatically segments the prostate, calculates PSA density, and detects suspicious areas with PIRADS > 3. Used by urologists and radiologists specializing in prostate cancer diagnosis.
- Myrian XP-LungNodule Option AI AI-powered lung nodule detection option with automatic detection of solid and sub-solid nodules, synchronized comparison of detected anomalies, and 92.4% sensitivity including ground-glass nodules. Used by chest and lung radiologists.
Quantifiable outcome
- 92.4% sensitivity for lung nodule detection including ground-glass nodules
- +2 more outcomes
Companies that use Intrasense
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles2 records
Intrasense technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability4 records
Feature6 records
Intrasense partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- GuerbetcoreGuerbet is a global leader in medical imaging and the parent company of Intrasense. The partnership focuses on co-development and distribution of DUOnco AI products (Liver, Bone, Pancreas). Guerbet announced FDA Breakthrough Device designation for DUOnco Pancreas and holds PMDA certification for Japan market. Guerbet opened share capital to Guerbet group in 2022-2023.
- ICM (Institut du Cancer de Montpellier)corePartnership with Montpellier Cancer Institute to validate and deploy the new oncology platform in real-life clinical situations with the objective of clinical routine use.
Scale indicators6 records
Recent moves7 records
Expansion highlights6 records
Intrasense competitors and assessment
Company assessmentDirect peers
- Vitrea (Canon Medical / Vital Images): Vitrea is a multi-modality advanced visualization platform from Canon Medical that, like Myrian, provides specialty clinical applications (oncology, cardiac, neuro, vascular) on top of a workstation. It competes head-to-head with Myrian in radiology departments seeking best-of-breed visualization with embedded clinical workflows.
- Aidoc: Aidoc is a clinical AI platform offering AI-powered detection and triage algorithms for radiology (CT, MR) integrated into PACS workflows. It is a direct competitor in AI lesion detection and workflow orchestration, with broader US market penetration and significant venture funding.
- Lunit: Lunit is a Korean medical AI company specializing in lesion detection in oncology (notably Lunit INSIGHT for chest and mammography). It competes with Intrasense's DUOnco and Myrian XP-LungNodule in AI-driven oncology imaging, with a similar CE-marked, multi-product approach.
- Icometrix: Icometrix (maker of ico*brain) is a brain imaging AI company whose products are actually distributed by Intrasense. Beyond this partnership, Icometrix competes directly in specialty clinical AI modules similar to Intrasense's strategy of embedding high-value clinical apps within a broader platform.
- Arterys (Tempus): Arterys, now part of Tempus, provides cloud-native AI-powered medical imaging workflows including oncology and cardiac analysis. It competes with Myrian in offering AI-augmented specialty viewers on a platform model.
- Mirada Medical: Mirada Medical offers advanced visualization and AI-based image analysis software for oncology and radiology. It directly overlaps with Intrasense's specialty clinical modules (e.g., Myrian XP-Prostate, Myrian XP-Lung) and competes for similar hospital and OEM channels.
Broad incumbents
- Philips IntelliSpace Portal: Philips IntelliSpace Portal is an enterprise multi-modality visualization and advanced analysis suite sold to large hospital systems. It overlaps with Myrian's multi-modality, multi-specialty positioning but is bundled into Philips' broader imaging hardware, PACS, and AI portfolio.
- Siemens Healthineers syngo.via: syngo.via is Siemens Healthineers' multi-modality reading and post-processing platform with embedded AI (AI-Rad Companion). It targets the same enterprise radiology buyer as Myrian but benefits from Siemens' installed imaging-modality base and global sales force.
- GE HealthCare AW Workstation / Edison: GE HealthCare's AW Workstation and Edison AI platform provide multi-modality visualization and AI applications sold to hospitals alongside GE imaging equipment. Direct overlap with Intrasense's Myrian + DUOnco positioning, with greater scale and capital.
- Carestream Health: Carestream sells Vue PACS and clinical viewing/workflow software to hospitals worldwide. It is an incumbent in radiology IT with overlapping visualization and workflow functionality, though its AI capabilities are less developed than Intrasense's DUOnco suite.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat6 records
Key risks5 records
Key highlights6 records
Customer concentration
Intrasense social profiles
Digital presenceIntrasense compliance and trust
Trust signalCompliance6 records
Intrasense financial estimates
Financial estimateRevenue estimate
Valuation estimate
Intrasense leadership team
Management profileNumber of profiles
Profiles5 records
Intrasense funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Intrasense M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Intrasense
What does Intrasense do?
Intrasense designs and develops Class II medical device software for AI-enhanced medical imaging, centered on the Myrian® multi-modality visualization platform supporting MRI, CT, mammography, tomosynthesis, and ultrasound. The portfolio includes the DUOnco™ family of AI lesion detection modules (Liver, Bone, Pancreas) and the Liflow® automated oncology follow-up application, all sold to radiology departments, oncology centers, and hospitals worldwide.
Is Intrasense a public or private company?
Intrasense is a public company. It is classified as public and is currently operating.
When was Intrasense founded?
Intrasense was founded in 2004. It employs 51 to 100 people.
Where is Intrasense based?
Intrasense is headquartered in Montpellier, France, in the Europe region.
How does Intrasense make money?
Two revenue lines are on record. Medical Imaging Software Licensing is the primary driver. The others are software Licenses and Updates.
Who are Intrasense's main competitors?
Direct peers on record are Vitrea (Canon Medical / Vital Images), Aidoc, Lunit, Icometrix, Arterys (Tempus) and Mirada Medical. Broad incumbents are Philips IntelliSpace Portal, Siemens Healthineers syngo.via, GE HealthCare AW Workstation / Edison and Carestream Health.
Does Intrasense have an API?
No public API is recorded for Intrasense.
What industry is Intrasense in?
Intrasense's product category is Medical Imaging Software. Its primary akta.pro industry code is HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software, with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 334510 and its SIC code is 3841.